| No headlines available for GLSAX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
5.75M |
| Category: |
Health |
| Total Expense Ratio: |
1.62% |
|
| PERFORMANCE & RISK | 31-Oct-09
| YTD Return: |
7.06% |
| 5y Avg Return: |
1.58% |
| Rank in Category (ytd): |
130 |
| % Rank in Category (ytd): |
78.79% |
| Beta (3y): |
0.74 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks long-term capital appreciation. The fund invests at least 80% of net assets in equity securities issued by U.S. and foreign companies with business operations in or related to health sciences. It invests 25% or more of assets in at least one of the following industry groups: healthcare; pharmaceuticals; biotechnology; medical supplies; medical services and medical devices. The fund may invest in health sciences companies of any size, including established large-cap companies that are expected to grow with the market and small-cap and mid-cap companies that may offer strong prospects for future growth. It is nondiversified. |
|
| Fund Profile |
|
Help
0.07 (0.75%) 
Summary
Add GLSAX to Portfolio 
Download Data
